Send us a text

The future of cancer treatment is on the horizon, but can we afford it, regulate it, and deliver it at scale?

In this episode of the HealthBiz Podcast, Dr. Jason Bock, Co-founder and CEO of CTMC, discusses the progress of CAR T cell therapy, the challenges of scaling manufacturing for personalized treatments, and how new payment and policy models can support broader access. He shares inspiring patient success stories, insights into the future of solid tumor therapies, and CTMC’s mission to bring advanced therapies to more patients, faster.

🎙️⚕️ABOUT DR. JASON BOCK
Dr. Jason Brock is the Co-Founder and CEO of CTMC. Jason has over twenty years of research and leadership experience in pharmaceuticals and biotech creating new divisions and companies from the ground up. He sits on several scientific advisory boards. He has a BS in Biology and PhD in Molecular and Cellular Physiology.


🎙️⚕️ABOUT HEALTH BIZ PODCAST
HealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

#healthcare #healthcarepodcast #healthcarebusiness #healthcarepolicy #healthinsurance #healthcaretechnology #caretalk #ctmc #cart #cartcelltherapy

Support the show

⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.